COMMITTEE & DIRECTORS
Behind every great organization is a team of dedicated leaders. Our team brings a wealth of experience from across the industry.

CTN2 Officers & Advisors: Phil Cestaro Executive Director, Karen Johnson, Steve Schwab, Steve Goodman President and CEO, Robert Davis, William Mason, and Ari VanderWalde Medical Director
CTN2 Officers & Advisors
Â
CTN2 Board of Directors
We are governed by a Board of Directors comprised of a representative from each participating institution, the UTHSC Chancellor, and from UTRF.
Â
SITE DIRECTORS
In order to sustain a successful, state-wide multi-site clinical trials network, each participating hospital appoints a Site Director. While executive level communication is maintained through Board representatives, CTN2 routinely works with each participating institution's Site Director as the lead on conduct of clinical trials. CTN2 develops working practice guidelines with each participating institution, customized to each institution's particular requirements, policies and environments. CTN2's site liaison and the Site Directors take the lead in developing and implementing those standards and operating procedures to facilitate prompt compliant and effective administration of clinical trials. The Site Director is also regularly consulted on potential and pending clinical trials in the pipeline. The Site Director is the main administrative contact for the TN-EDW data transfer facilitation, and inevitably a key person in the hospital on deploying TN-EDW as a tool for researchers.
Â
How about we talk some time?
Questions about our organization, structure, or participation benefits? We'd love to hear from you!